29 June 2022
Notice of Results – Analyst and Investor Briefings
Shield Therapeutics plc will announce its final results for the year ended 31 December 2021 on Thursday 30 June 2022.
A briefing open to analysts will take place remotely via Zoom on Thursday 30 June 2022 at 13.30 (BST). If you would like the details of this call, please contact Walbrook PR on email@example.com.
CEO, Greg Madison, CFO, Hans-Peter Rudolf, and CMO, José Menoyo MD, will also be hosting a live online presentation relating to the final results via the Investor Meet Company platform at 16.30 (BST) on Thursday 30 June. The presentation is open to all existing and potential shareholders.
Investors can sign up to Investor Meet Company for free and register for the presentation here: https://www.investormeetcompany.com/shield-therapeutics-plc/register-investor
Investors who already follow Shield on the Investor Meet Company platform will automatically be invited.
Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the “Ask a Question” function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards and via the Company’s website.